Roberta Giuffrida

InstitutionUniversity of Messina
AddressMessina
Italy
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 12 Covid-19 publications, with a maximum of 4 publications in May 2020
    All Publications
    Bar chart showing 31 publications over 7 distinct years, with a maximum of 11 publications in 2020
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Conforti C, Lallas A, Argenziano G, Dianzani C, Di Meo N, Giuffrida R, Kittler H, Malvehy J, Marghoob AA, Soyer HP, Zalaudek I. Impact of the COVID-19 Pandemic on Dermatology Practice Worldwide: Results of a Survey Promoted by the International Dermoscopy Society (IDS). Dermatol Pract Concept. 2021 Jan; 11(1):e2021153. PMID: 33614221.
      Citations: 6     
    2. Conforti C, Dianzani C, Agozzino M, Giuffrida R, Marangi GF, Meo ND, Morariu SH, Persichetti P, Segreto F, Zalaudek I, Neagu N. Cutaneous Manifestations in Confirmed COVID-19 Patients: A Systematic Review. Biology (Basel). 2020 Dec 05; 9(12). PMID: 33291502.
      Citations: 9     
    3. Conforti C, di Meo N, Giuffrida R, Zalaudek I. Management of patients with melanoma and non-melanoma skin cancers in the coronavirus disease 2019 era. Chin Med J (Engl). 2020 09 05; 133(17):2017-2019. PMID: 32530883.
      Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
    4. Conforti C, Zalaudek I, Giuffrida R, Zorat F, Grillo A, Colapietro N, Francica M, di Meo N. "COVID-Mask": An atypical livedoid manifestation of COVID-19 observed in a Northern Italy hospital. Dermatol Ther. 2020 07; 33(4):e13701. PMID: 32472566.
      Citations: 6     Fields:    Translation:HumansCellsPHPublic Health
    5. Mastrolonardo M, Romita P, Bonifazi E, Giuffrida R, Lotti T, Foti C, Bonamonte D. The management of the outbreak of acral skin manifestations in asymptomatic children during COVID-19 era. Dermatol Ther. 2020 Jul; 33(4):e13617. PMID: 32424886.
      Citations: 6     Fields:    Translation:HumansCellsPHPublic Health
    6. Grandolfo M, Romita P, Bonamonte D, Cazzato G, Hansel K, Stingeni L, Conforti C, Giuffrida R, Foti C. Drug reaction with eosinophilia and systemic symptoms syndrome to hydroxychloroquine, an old drug in the spotlight in the COVID-19 era. Dermatol Ther. 2020 Jul; 33(4):e13499. PMID: 32362051.
      Citations: 7     Fields:    Translation:HumansCellsPHPublic Health
    7. Conforti C, Giuffrida R, Dianzani C, Di Meo N, Zalaudek I. Biologic therapy for psoriasis during the COVID-19 outbreak: The choice is to weigh risks and benefits. Dermatol Ther. 2020 07; 33(4):e13490. PMID: 32358864.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    8. Conforti C, Giuffrida R, Zalaudek I, Di Meo N. Doxycycline, a widely used antibiotic in dermatology with a possible anti-inflammatory action against IL-6 in COVID-19 outbreak. Dermatol Ther. 2020 Jul; 33(4):e13437. PMID: 32314492.
      Citations: 12     Fields:    Translation:HumansPHPublic Health
    9. Conforti C, Giuffrida R, Di Meo N, Zalaudek I. Management of advanced melanoma in the COVID-19 era. Dermatol Ther. 2020 Jul; 33(4):e13444. PMID: 32323399.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
    10. Caldaria A, Conforti C, Di Meo N, Dianzani C, Jafferany M, Lotti T, Zalaudek I, Giuffrida R. COVID-19 and SARS: Differences and similarities. Dermatol Ther. 2020 Jul; 33(4):e13395. PMID: 32277530.
      Citations: 8     Fields:    Translation:HumansCellsPHPublic Health
    11. Conforti C, Cannavò SP, Jafferany M, Dianzani C, Di Meo N, Lotti T, Zalaudek I, Giuffrida R. Coronavirus disease 2019: Facts and controversies. Dermatol Ther. 2020 Jul; 33(4):e13366. PMID: 32239628.
      Citations: 4     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    12. Conforti C, Giuffrida R, Dianzani C, Di Meo N, Zalaudek I. COVID-19 and psoriasis: Is it time to limit treatment with immunosuppressants? A call for action. Dermatol Ther. 2020 07; 33(4):e13298. PMID: 32157783.
      Citations: 34     Fields:    Translation:HumansPHPublic Health
    Giuffrida's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (94)
    Explore
    _
    Co-Authors (35)
    Explore
    _
    Similar People (60)
    Explore
    _